Found: 2
Select item for more details and to access through your institution.
MAINTENANCE RITUXIMAB IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL IN MANTLE CELL LYMPHOMA PATIENTS RESPONDING TO INDUCTION THERAPY WITH BENDAMUSTINE + RITUXIMAB (BR).
- Published in:
- Hematological Oncology, 2019, v. 37, p. 405, doi. 10.1002/hon.75_2631
- By:
- Publication type:
- Article
MAINTENANCE RITUXIMAB IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL IN MANTLE CELL LYMPHOMA PATIENTS RESPONDING TO INDUCTION THERAPY WITH BENDAMUSTINE + RITUXIMAB (BR).
- Published in:
- Hematological Oncology, 2019, v. 37, p. 405, doi. 10.1002/hon.75_2631
- By:
- Publication type:
- Article